Cargando…
Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer
The androgen receptor (AR) is a prostate master transcription factor. It binds to genetic enhancers, where it regulates gene activity and plays a fundamental role in prostate pathophysiology. Previous work has demonstrated that AR-DNA binding is systematically and consistently reprogrammed during pr...
Autores principales: | Severson, Tesa, Qiu, Xintao, Alshalalfa, Mohammed, Sjöström, Martin, Quigley, David, Bergman, Andries, Long, Henry, Feng, Felix, Freedman, Matthew L., Zwart, Wilbert, Pomerantz, Mark M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069737/ https://www.ncbi.nlm.nih.gov/pubmed/35509021 http://dx.doi.org/10.1186/s13148-022-01278-8 |
Ejemplares similares
-
Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential
por: Kneppers, Jeroen, et al.
Publicado: (2022) -
Epigenetic and transcriptional analysis reveals a core transcriptional program conserved in clonal prostate cancer metastases
por: Severson, Tesa M., et al.
Publicado: (2021) -
Androgen receptor DNA binding and chromatin accessibility profiling in prostate cancer
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2015) -
Radium-223 Treatment of Patients with Metastatic Castration Resistant Prostate Cancer: Biomarkers for Stratification and Response Evaluation
por: van der Zande, Kim, et al.
Publicado: (2021) -
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
por: Pomerantz, Mark M., et al.
Publicado: (2015)